Genentech Inc.: The South San Francisco-based biotechnology...
- Share via
From Times Staff and Wire Reports
Genentech Inc.: The South San Francisco-based biotechnology company said second-quarter profits fell 45% to $5.3 million. Revenue rose 15% to $112.5 million. The main reason for the earnings decline was $7.2 million in expenses related to a proposed merger with Roche Holdings Inc., the company said.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
